We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$6.37B
AUM Growth
+$1.11B
Cap. Flow
+$527M
Cap. Flow %
8.27%
Top 10 Hldgs %
34.58%
Holding
1,211
New
40
Increased
703
Reduced
424
Closed
39
Avg Time Held
5.1 quarters
Top 10 Avg Time Held
5.4 quarters
Top 20 Avg Time Held
4.1 quarters

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$34.5M
2
AAPL icon
Apple
AAPL
+$29.1M
3
BAC icon
Bank of America
BAC
+$21.6M
4
AMZN icon
Amazon
AMZN
+$21M
5
TSLA icon
Tesla
TSLA
+$12.7M

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$6.12M
2
EL icon
Estee Lauder
EL
+$5.61M
3
CARR icon
Carrier Global
CARR
+$5.1M
4
GIS icon
General Mills
GIS
+$4.64M
5
TJX icon
TJX Companies
TJX
+$4.56M

Sector Composition

Rank Sector Weight
1 Technology 32.37%
2 Consumer Discretionary 14.58%
3 Healthcare 11.36%
4 Financials 10.36%
5 Communication Services 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BEAM icon
1176
Beam Therapeutics
BEAM
$2.6B
– –
-2,342
Closed -$204K –
CELH icon
1177
Celsius Holdings
CELH
$7.18B
– –
-7,611
Closed -$229K –
CVAC icon
1178
DELISTED
CureVac
CVAC
– –
-5,964
Closed -$326K –
DNLI icon
1179
Denali Therapeutics
DNLI
$3.03B
– –
-4,315
Closed -$218K –
EBS icon
1180
Emergent Biosolutions
EBS
$358M
– –
-7,313
Closed -$366K –
EYE icon
1181
National Vision
EYE
$1.35B
– –
-4,385
Closed -$249K –
FRT icon
1182
Federal Realty Investment Trust
FRT
$9.25B
– –
-3,630
Closed -$428K –
JAMF icon
1183
DELISTED
Jamf
JAMF
– –
-5,311
Closed -$205K –
OPLN icon
1184
Openlane
OPLN
$4.44B
– –
-17,850
Closed -$293K –
NCNO icon
1185
nCino
NCNO
$2.07B
– –
-6,378
Closed -$453K –
NEO icon
1186
NeoGenomics
NEO
$2.08B
– –
-6,564
Closed -$317K –
NKTR icon
1187
Nektar Therapeutics
NKTR
$1.36B
– –
-1,376
Closed -$371K –
NTCT icon
1188
NETSCOUT
NTCT
$2.91B
– –
-11,161
Closed -$301K –
PACB icon
1189
Pacific Biosciences
PACB
$653M
– –
-9,131
Closed -$233K –
RDFN icon
1190
DELISTED
Redfin
RDFN
– –
-5,905
Closed -$296K –
RDN icon
1191
Radian Group
RDN
$4.48B
– –
-9,056
Closed -$206K –
SLG icon
1192
SL Green Realty
SLG
$3.45B
– –
-7,530
Closed -$533K –
SPT icon
1193
Sprout Social
SPT
$669M
– –
-2,102
Closed -$256K –
TDOC icon
1194
Teladoc Health
TDOC
$1.08B
– –
-1,617
Closed -$205K –
TDS icon
1195
Telephone and Data Systems
TDS
$4B
– –
-14,904
Closed -$291K –
TGTX icon
1196
TG Therapeutics
TGTX
$8.46B
– –
-6,021
Closed -$200K –
TREE icon
1197
LendingTree
TREE
$348M
– –
-1,724
Closed -$241K –
TWST icon
1198
Twist Bioscience
TWST
$10.1B
– –
-2,220
Closed -$237K –
UPWK icon
1199
Upwork
UPWK
$1.08B
– –
-6,276
Closed -$283K –
MMAT icon
1200
DELISTED
Meta Materials Inc. Common Stock
MMAT
– –
-103
Closed -$60K –

Similar funds

Xponance's Q4 2021 Portfolio in Review

As of Q4 2021, Xponance held 1,211 positions worth $6.37B, up 21% from $5.27B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Xponance deployed $527M of net new capital in Q4 2021, opening 40 new positions and adding to 703 existing holdings. Its largest new stake was Wolfspeed: 12,874 shares worth $1.44M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Entergy, an estimated $6.12M trimmed.

  • Xponance's largest Q4 2021 buy was Wolfspeed: 12,874 shares worth $1.44M.
  • Xponance added most to Microsoft in Q4 2021, an estimated $34.5M increase.
  • Xponance's biggest Q4 2021 reduction was Entergy, cutting an estimated $6.12M.
  • Xponance fully exited Kansas City Southern in Q4 2021, selling an estimated $1.91M.
  • Xponance's ten largest holdings make up 35% of its $6.37B portfolio in Q4 2021.
  • Xponance opened 40 new positions and closed 39 in Q4 2021.
  • Xponance's portfolio value rose 21% quarter-over-quarter to $6.37B.

Based on Xponance's 13F filing for Q4 2021, filed 31 Jan 2022.